Cargando…

Correction to: The clinician’s guide to prevention and treatment of osteoporosis

Detalles Bibliográficos
Autores principales:	LeBoff, M. S., Greenspan, S. L., Insogna, K. L., Lewiecki, E. M., Saag, K. G., Singer, A. J., Siris, E. S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer London 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546943/ https://www.ncbi.nlm.nih.gov/pubmed/35900384 http://dx.doi.org/10.1007/s00198-022-06479-8

Ejemplares similares

The clinician’s guide to prevention and treatment of osteoporosis
por: LeBoff, M. S., et al.
Publicado: (2022)

Clinician’s Guide to Prevention and Treatment of Osteoporosis
por: Cosman, F., et al.
Publicado: (2014)

Erratum to: Clinician’s guide to prevention and treatment of osteoporosis
por: Cosman, F., et al.
Publicado: (2015)

Osteoanabolic Agents for Osteoporosis
por: Haas, Andrea V, et al.
Publicado: (2018)

Lasofoxifene for the prevention and treatment of postmenopausal osteoporosis
por: Lewiecki, E Michael
Publicado: (2009)

Animal versus plant protein and adult bone health: A systematic review and meta-analysis from the National Osteoporosis Foundation
por: Shams-White, Marissa M., et al.
Publicado: (2018)

Correction to: How has COVID-19 affected the treatment of osteoporosis? An IOF-NOF-ESCEO global survey
por: Fuggle, N.R., et al.
Publicado: (2021)

Correction: UK clinical guideline for the prevention and treatment of osteoporosis
por: Gregson, Celia L., et al.
Publicado: (2022)

Forearm bone mineral density and fracture incidence in postmenopausal women with osteoporosis: results from the ACTIVExtend phase 3 trial
por: Watts, N.B., et al.
Publicado: (2020)

Management of osteoporosis
por: Lewiecki, E Michael
Publicado: (2004)

Safety and tolerability of denosumab for the treatment of postmenopausal osteoporosis
por: Lewiecki, E Michael
Publicado: (2011)

Operationalizing Treat-to-Target for Osteoporosis
por: Lewiecki, E. Michael
Publicado: (2021)

Intravenous zoledronic acid for the treatment of osteoporosis: The evidence of its therapeutic effect
por: Lewiecki, E Michael
Publicado: (2010)

Denosumab: an investigational drug for the management of postmenopausal osteoporosis
por: Lewiecki, E Michael
Publicado: (2008)

Correction to: Cost Effectiveness Analyses of Interventions for Osteoporosis in Men: A Systematic Literature Review
por: Li, Nannan, et al.
Publicado: (2023)

Correction to: Melatonin prevents bone destruction in mice with retinoic acid-induced osteoporosis
por: Wang, Xudong, et al.
Publicado: (2021)

Persistence at 24 months with denosumab among postmenopausal women with osteoporosis: results of a prospective cohort study
por: Silverman, Stuart L., et al.
Publicado: (2018)

Correction: Clinicians’ perspectives on incidentally discovered silent brain infarcts – A qualitative study
por: Leung, Lester Y., et al.
Publicado: (2018)

Correction to: Real-world bone turnover marker use: impact on treatment decisions and fracture
por: Lane, N. E., et al.
Publicado: (2021)

The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design
por: Hooven, F. H., et al.
Publicado: (2009)

Romosozumab, clinical trials, and real-world care of patients with osteoporosis
por: Lewiecki, E. Michael
Publicado: (2020)

Correction: Real-world effectiveness of osteoporosis treatments in Germany
por: O’Kelly, James, et al.
Publicado: (2022)

Correction: Novel formulations of oral bisphosphonates in the treatment of osteoporosis
por: Fuggle, Nicholas, et al.
Publicado: (2023)

Anabolic therapy for osteoporosis: update on efficacy and safety
por: Bandeira, Leonardo, et al.
Publicado: (2022)

Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation
por: Weaver, C. M., et al.
Publicado: (2015)

Correction to: Clinician Testing and Treatment Thresholds for Management of Urinary Tract Infection
Publicado: (2023)

Estimation of Long‐Term Efficacy of Denosumab Treatment in Postmenopausal Women With Osteoporosis: A FRAX‐ and Virtual Twin‐Based Post Hoc Analysis From the FREEDOM and FREEDOM Extension Trials
por: Siris, Ethel, et al.
Publicado: (2020)

Sclerostin inhibition: a novel therapeutic approach in the treatment of osteoporosis
por: Shah, Arti D, et al.
Publicado: (2015)

Progress in osteoporosis and fracture prevention: focus on postmenopausal women
por: Saag, Kenneth G, et al.
Publicado: (2009)

Correction to: Autophagy in bone homeostasis and the onset of osteoporosis
por: Yin, Xing, et al.
Publicado: (2020)

Persistence at 12 months with denosumab in postmenopausal women with osteoporosis: interim results from a prospective observational study
por: Silverman, S. L., et al.
Publicado: (2014)

Advancement in the Treatment of Osteoporosis and the Effects on Bone Healing
por: Kushchayeva, Yevgeniya, et al.
Publicado: (2022)

Failure to perceive increased risk of fracture in women 55 years and older: the Global Longitudinal Study of Osteoporosis in Women (GLOW)
por: Siris, E. S., et al.
Publicado: (2010)

Factors associated with diagnosis and treatment of osteoporosis in older adults
por: Nayak, S., et al.
Publicado: (2009)

Effect of vitamin D on serum markers of bone turnover in SLE in a randomised controlled trial
por: Tedeschi, Sara K., et al.
Publicado: (2019)

Biomechanical Computed Tomography analysis (BCT) for clinical assessment of osteoporosis
por: Keaveny, T.M., et al.
Publicado: (2020)

Publisher Correction to: Development of the Asia Pacific Consortium on Osteoporosis (APCO) framework: clinical standards of care for the screening, diagnosis, and management of osteoporosis in the Asia-Pacific region
por: Chandran, M., et al.
Publicado: (2021)

When, Where and How Osteoporosis-Associated Fractures Occur: An Analysis from the Global Longitudinal Study of Osteoporosis in Women (GLOW)
por: Costa, Aline G., et al.
Publicado: (2013)

Correction: Pathogenesis of Age-Related Osteoporosis: Impaired Mechano-Responsiveness of Bone Is Not the Culprit
por: Leppänen, Olli V., et al.
Publicado: (2008)

Correction: Pathogenesis of Age-Related Osteoporosis: Impaired Mechano-Responsiveness of Bone Is Not the Culprit
por: Leppänen, Olli V., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_nef8uc5gqr6lii7td564uk3jeg